Transforming growth factors and control of neoplastic cell growth
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Transforming growth factors (TGFs) are peptides that affect the growth and phenotypic of cultured cells and bring about in nonmalignant fibroblastic cells phenotypic properties that resemble those of malignant cells. Two types of TGFs have been well characterized. One of these, TGFβ, is related to epidermal growth factor (EGF) and binds to the EGF receptor, whereas the other. TGFβ, is not structurally or functionally related to TGFβ or EGF and mediates its effects via distinct receptors. TGFβ is produced by a variety of normal and malignant cells. Depending upon the assay system employed, TGFβ has both growth‐inhibitory and growth‐stimulating properties. Many of the mitogenic effects of TGFβ are probably an indirect result of the activation of certain growth factor genes in the target cell. The ubiquitous nature of the TGFβ receptor and the production of TGFβ in a latent form by most cultured cells suggests that the differing cellular responses to TGFβ are regulated either by events involved in the activation of the factor or by postreceptor mechanisms. The combined effects of TGFβ with other growth factors or inhibitors evidently play a central role in the control of normal and malignant cellular growth as well as in cell differentiation and morphogenesis. Since transforming growth factor as a concept has partially proven misleading and insufficient, there is a need to find a new nomenclature for these regulators of cellular growth and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Grotendorst, G. R., Martin, G. R., Pencev, D., Sodek, J., & Harvey, A. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112243 · Cited by 275
Cited by
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
Lyons, R. M., Keski-Oja, J., & Moses, H. L. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.5.1659 · Cited by 963
Self-citationCell-Associated Plasminogen Activation: Regulation and Physiological Functions
Saksela, O., & Rifkin, D. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.000521 · Cited by 818
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.
Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777
Self-citationOft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996) · Genes & Development · doi:10.1101/gad.10.19.2462 · Cited by 681
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Raghow, R., Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112950 · Cited by 464
Self-citationLaiho, M., Saksela, O., Andreasen, P. A., & Keski-Oja, J. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2403 · Cited by 437
Self-citationIn vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L., & Zern, M. A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2477 · Cited by 415
Saksela, O., Moscatelli, D., & Rifkin, D. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.957 · Cited by 367
Regulation of intestinal epithelial cell growth by transforming growth factor type beta.
Barnard, J. A., Beauchamp, R. D., Coffey, R. J., & Moses, H. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1578 · Cited by 338
Self-citationWong, H. L., & Wahl, S. M. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-74781-6_18 · Cited by 295
Growth factor binding to the pericellular matrix and its importance in tissue engineering☆
MACRI, L., SILVERSTEIN, D., & CLARK, R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.015 · Cited by 292
Gentry, L. E., Lioubin, M. N., Purchio, A. F., & Marquardt, H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4162 · Cited by 284
Schultz-Cherry, S., Ribeiro, S., Gentry, L., & Murphy-Ullrich, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47086-x · Cited by 272
Active and latent forms of transforming growth factor beta activity in synovial effusions.
Fava, R., Olsen, N., Keski-Oja, J., Moses, H., & Pincus, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.291 · Cited by 261
Self-citationLaiho, M., Saksela, O., & Keski-Oja, J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45403-8 · Cited by 257
Self-citationTransforming Growth Factor-β: Latent Forms, Binding Proteins and Receptors
Miyazono, K., Ichijo, H., & Heldin, C.-H. (1993) · Growth Factors · doi:10.3109/08977199309029130 · Cited by 209
Metadata
- Authors
- Keski‐Oja, J., Leof, E. B., Lyons, R. M., Coffey, R. J., & Moses, H. L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1987-02
- Volume
- 33
- Issue
- 2
- Pages
- 95-107
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1998454879
- Cited by
- 138
- References
- 2
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.